{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:36:13Z","timestamp":1789756573610,"version":"4.0.1"},"reference-count":12,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,8,1]]},"abstract":"<jats:p>Autoimmune hepatitis is a severe liver disease in which \u223c10% of patients do not respond to standard treatment. We describe a new rescue therapy using anti-CD20 monoclonal antibodies (rituximab). Complete remission was obtained and maintained by using low doses of immunosuppressive drugs with repeated anti-CD20 infusions.<\/jats:p>","DOI":"10.1542\/peds.2011-1900","type":"journal-article","created":{"date-parts":[[2013,7,2]],"date-time":"2013-07-02T00:46:43Z","timestamp":1372726003000},"page":"e526-e530","source":"Crossref","is-referenced-by-count":71,"title":["Successful Treatment of Refractory Autoimmune Hepatitis With Rituximab"],"prefix":"10.1542","volume":"132","author":[{"given":"Daniel","family":"D\u2019Agostino","sequence":"first","affiliation":[{"name":"Pediatric Gastroenterology-Hepatology Division, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Costaguta","sequence":"additional","affiliation":[{"name":"Unidad de H\u00edgado y Trasplante Hep\u00e1tico, Sanatorio de Ni\u00f1os, Rosario, Argentina; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"\u00c1lvarez","sequence":"additional","affiliation":[{"name":"P\u00e9diatrie, CHU Sainte-Justine Universit\u00e9 de Montr\u00e9al, Montreal, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2013,8,1]]},"reference":[{"issue":"1","key":"2021120900160066100_B1","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMra050408","article-title":"Autoimmune hepatitis.","volume":"354","author":"Krawitt","year":"2006","journal-title":"N Engl J Med"},{"issue":"4","key":"2021120900160066100_B2","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/hep.1840180435","article-title":"Meeting report: International Autoimmune Hepatitis Group.","volume":"18","author":"Johnson","year":"1993","journal-title":"Hepatology"},{"issue":"1","key":"2021120900160066100_B3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cld.2005.10.009","article-title":"Autoimmune hepatitis and primary sclerosing cholangitis.","volume":"10","author":"Alvarez","year":"2006","journal-title":"Clin Liver Dis"},{"issue":"1","key":"2021120900160066100_B4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2010.08076.x","article-title":"The effect of rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune diseases.","volume":"149","author":"Cooper","year":"2010","journal-title":"Br J Haematol"},{"issue":"5","key":"2021120900160066100_B5","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/gut.42.5.721","article-title":"Liver\/kidney microsomal antibody type 1 and liver cytosol antibody type 1 concentrations in type 2 autoimmune hepatitis.","volume":"42","author":"Muratori","year":"1998","journal-title":"Gut"},{"issue":"3","key":"2021120900160066100_B6","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0016-5085(99)70186-1","article-title":"Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis.","volume":"116","author":"Lapierre","year":"1999","journal-title":"Gastroenterology"},{"issue":"3","key":"2021120900160066100_B7","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1053\/j.gastro.2005.12.020","article-title":"Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2.","volume":"130","author":"Ma","year":"2006","journal-title":"Gastroenterology"},{"issue":"5","key":"2021120900160066100_B8","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1478-3231.2006.01262.x","article-title":"Successful treatment of autoimmune hepatitis and idiopathic thrombocytopenic purpura with the monoclonal antibody, rituximab: case report and review of literature.","volume":"26","author":"Santos","year":"2006","journal-title":"Liver Int"},{"issue":"5","key":"2021120900160066100_B9","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1097\/MPG.0b013e31802e9739","article-title":"Giant cell hepatitis and autoimmune hemolytic autoimmune anemia successfully treated with rituximab.","volume":"44","author":"Miloh","year":"2007","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"4","key":"2021120900160066100_B10","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1097\/MPG.0b013e3182359002","article-title":"Giant cell hepatitis and immune thrombocytopenic purpura: reversal of liver failure with rituximab therapy.","volume":"55","author":"Shores","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"1","key":"2021120900160066100_B11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jpeds.2010.12.050","article-title":"Giant cell hepatitis with autoimmune hemolytic anemia in early childhood: long-term outcome in 16 children.","volume":"159","author":"Maggiore","year":"2011","journal-title":"J Pediatr"},{"issue":"8","key":"2021120900160066100_B12","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S1470-2045(09)70161-5","article-title":"Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project.","volume":"10","author":"Carson","year":"2009","journal-title":"Lancet Oncol"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/132\/2\/e526\/1091242\/peds_2011-1900.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/132\/2\/e526\/1091242\/peds_2011-1900.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T05:49:06Z","timestamp":1639028946000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/132\/2\/e526\/31408\/Successful-Treatment-of-Refractory-Autoimmune"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,1]]},"references-count":12,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2013,8,1]]},"published-print":{"date-parts":[[2013,8,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2011-1900","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,1]]}}}